V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290006985 | 290007249 | 1.87 | 76.4 | Curative (C) | null | 2018-03-23 | Trial Unspecified | Y | null | 290021624 | COMPARE TRIAL |
| 290006986 | 290007249 | 1.72 | 76.4 | Palliative (P) | 2017-06-06 | 2017-06-07 | CISPLATIN + RT | 02 | N | 290021624 | EVEROLIMUS |
| 290006987 | 290005323 | 1.68 | 90.9 | Curative (C) | 2018-08-08 | 2018-11-10 | Trial Unspecified | 02 | Y | 290021635 | CISPLATIN + RT |
| 290006988 | 290005325 | 1.76 | 77.4 | null | 2014-09-03 | 2014-09-04 | Capecitabine | N | N | 290021637 | LANREOTIDE |
| 290006989 | 290005326 | 1.76 | 95.6 | Palliative (P) | 2016-04-26 | 2016-05-17 | Vinorelbine (oral) | 2 | N | 290021638 | CETUXIMAB |
| 290006990 | 290007251 | 1.72 | 55.5 | Palliative (P) | 2015-11-11 | 2015-11-26 | Cisplatin 7 day | 2 | N | 290021638 | CARBOPLATIN + PACLITAXEL |
| 290006991 | 290005328 | 1.76 | 64.5 | null | 2018-11-21 | 2018-11-26 | PACLITAXEL | 2 | N | 290021670 | TRIAL |
| 290006992 | 290005329 | 1.76 | null | Palliative (P) | null | 2019-02-01 | Sunitinib | N | N | 290021673 | DOCETAXEL |
| 290006993 | 290005330 | 1.5 | null | Curative (C) | 2017-08-16 | 2017-09-20 | Carboplatin + Paclitaxel (3 weekly) | N | N | 290021673 | CARBOPLATIN + PACLITAXEL |
| 290006994 | 290005330 | 1.6 | 77.1 | Palliative (P) | 2014-07-30 | 2014-08-26 | Trastuzumab Subcutaneous | 02 | N | 290021673 | CABAZITAXEL |
| 290006995 | 290005330 | null | 69.45 | Palliative (P) | 2017-09-24 | 2017-09-24 | LANREOTIDE | N | N | 290021673 | TRIFLURIDINE + TIPIRACIL |
| 290006996 | 290005331 | null | 60.8 | Palliative (P) | 2014-04-05 | 2014-04-05 | Cisplatin + Radiotherapy | N | null | 290021693 | CAPECITABINE |
| 290006997 | 290005331 | 1.46 | null | null | 2014-11-24 | 2014-12-09 | CAPECITABINE + OXALIPLATIN + RT | 02 | N | 290021693 | CAPECITABINE |
| 290006999 | 290005333 | 1.68 | 51 | Palliative (P) | 2016-12-16 | 2016-12-17 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 290021699 | CARBO + FLUOROURACIL |
| 290007000 | 290005333 | 1.72 | 78 | Disease modification (D) | 2013-09-14 | 2013-10-21 | CARBOPLATIN + PACLITAXEL | N | N | 290021699 | CYCLOPHOSPHAMIDE + LENALIDOMIDE |
| 290007001 | 290005333 | 1.55 | 84.5 | Adjuvant (A) | 2014-09-08 | 2014-09-08 | Capecitabine + Cisplatin + RT | Y | N | 290021699 | CAPECITABINE + OXALIPLATIN |
| 290007002 | 290005333 | null | 99.3 | Palliative (P) | 2015-12-10 | 2015-12-31 | MITOMYCIN | 02 | N | 290021699 | CAPECITABINE + OXALIPLATIN |
| 290007003 | 290005334 | 1.55 | 65 | Palliative (P) | 2014-01-29 | 2014-02-12 | Cetuximab 14 day | N | N | 290021710 | CARBOPLATIN |
| 290007004 | 290005335 | 0 | 61.8 | Palliative (P) | 2017-09-16 | 2017-09-29 | CARBOPLATIN + RT | N | N | 290021722 | CAPECITABINE |
| 290007005 | 290005336 | 1.79 | 90.2 | Palliative (P) | 2016-03-06 | 2016-04-17 | CAPECITABINE + RT | N | N | 290021724 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 290007006 | 290007258 | null | 65 | Palliative (P) | 2017-01-25 | 2017-02-02 | PACLITAXEL + TRASTUZUMAB | N | N | 290021725 | IPILIMUMAB + NIVOLUMAB |
| 290007007 | 290005337 | null | 95 | Disease modification (D) | 2015-08-02 | 2015-08-04 | CAPECITABINE + RT | N | Y | 290021726 | DA |
| 290007008 | 290005338 | 1.76 | null | Curative (C) | 2014-12-30 | 2015-01-26 | Carboplatin + Etoposide iv&po | N | Y | 290021728 | CISPLATIN + ETOPOSIDE |
| 290007009 | 290007259 | 1.76 | 65 | Palliative (P) | 2016-12-23 | 2016-12-23 | Cetuximab+Cisplatin+FU (> Cycle 2) | 2 | N | 290021729 | Y-90 |
| 290007010 | 290007259 | 1.68 | 46.3 | null | 2016-08-14 | 2016-09-09 | REGORAFENIB | N | N | 290021729 | LANREOTIDE |
| 290007011 | 290007259 | 1.58 | 50.8 | Curative (C) | null | 2016-08-18 | Paclitaxel (2 or 3 weekly) | N | null | 290021729 | CETUXIMAB + RT |
| 290007012 | 290005340 | 1.62 | 118.55 | Curative (C) | 2018-02-04 | 2018-02-06 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 290021733 | IVE |
| 290007013 | 290005341 | 1.71 | 101.7 | Curative (C) | 2015-10-08 | 2015-10-09 | LANREOTIDE | 1 | N | 290021735 | CAPECITABINE + OXALIPLATIN |
| 290007014 | 290005342 | 1.77 | 55 | Adjuvant (A) | 2016-12-31 | 2017-01-18 | CAPECITABINE + RT | N | N | 290021738 | BALLAD TRIAL |
| 290007015 | 290005342 | 1.55 | 51.1 | Not known (9) | 2016-02-22 | 2016-02-23 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 290021738 | DOCETAXEL |
| 290007016 | 290005343 | 1.66 | 122.1 | Not known (9) | 2014-01-05 | 2014-01-05 | CISPLATIN + RT | N | N | 290021743 | BORTEZOMIB + THALIDOMIDE |
| 290007017 | 290005344 | 1.63 | 61.4 | Not known (9) | 2014-04-10 | 2014-04-25 | Capecitabine | N | N | 290021744 | CARBOPLATIN + ETOPOSIDE |
| 290007018 | 290005349 | null | 53.9 | Palliative (P) | 2018-05-25 | 2018-05-25 | Cisplatin + Radiotherapy | N | null | 290021748 | CISPLATIN + RT |
| 290007019 | 290005351 | 1.56 | 70.7 | Palliative (P) | 2013-08-08 | 2013-08-21 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 290021748 | IRINOTECAN |
| 290007020 | 290005352 | 1.59 | 69 | null | 2015-08-17 | 2015-08-17 | CAPECITABINE + RT | 02 | N | 290021751 | CISPLATIN + RT |
| 290007021 | 290005352 | 1.68 | 76.7 | Palliative (P) | null | 2014-11-06 | Etoposide oral | N | N | 290021751 | CETUXIMAB |
| 290007022 | 290005353 | 1.76 | 0 | null | 2014-11-16 | 2014-11-17 | Carboplatin + Etoposide iv&po | 2 | N | 290021760 | CAPECITABINE |
| 290007023 | 290005354 | 1.83 | 66.6 | null | 2017-02-16 | 2017-03-15 | Capecitabine | null | N | 290021767 | CETUXIMAB |
| 290007024 | 290005355 | 1.6 | 48 | Palliative (P) | 2013-05-15 | 2013-06-04 | Cisplatin | 02 | N | 290021768 | TRASTUZUMAB + VINORELBINE |
| 290007025 | 290005357 | 1.79 | null | Adjuvant (A) | 2018-09-13 | 2018-09-14 | Cetuximab 7 day (Cycle 1) | Y | N | 290021770 | CAPECITABINE + OXALIPLATIN |
| 290007026 | 290005359 | 1.48 | 64.2 | Neo-adjuvant (N) | 2015-11-05 | 2015-12-07 | Sunitinib | 02 | N | 290021771 | OXALIPLATIN + MDG + PANITUMUMAB |
| 290007027 | 290005360 | 1.67 | 93 | Palliative (P) | 2017-04-12 | 2017-05-14 | Everolimus 10mg | 02 | N | 290021774 | SUNITINIB |
| 290007028 | 290007267 | 1.6 | 53.2 | Adjuvant (A) | 2014-03-24 | 2014-04-21 | LANREOTIDE | N | N | 290021778 | CAPECITABINE |
| 290007029 | 290005362 | 1.59 | 53.2 | Adjuvant (A) | 2018-08-26 | 2018-08-27 | CARBOPLATIN + RT | 2 | N | 290021780 | CAPECITABINE + OXALIPLATIN |
| 290007030 | 290005363 | null | null | Curative (C) | 2013-12-29 | 2014-01-13 | Capecitabine + Oxaliplatin 21day | N | N | 290021789 | CARBOPLATIN + ETOPOSIDE |
| 290007031 | 290005363 | null | null | Palliative (P) | 2015-01-01 | 2015-01-10 | TRASTUZUMAB | 02 | null | 290021789 | IPILIMUMAB + NIVOLUMAB |
| 290007032 | 290008023 | 0 | 0 | null | 2014-06-27 | 2014-12-27 | LANREOTIDE | 02 | N | 290021797 | LANREOTIDE |
| 290007033 | 290008023 | 1.57 | 51.3 | Palliative (P) | 2018-08-21 | 2018-09-02 | OCTREOTIDE | 2 | Y | 290021797 | CARBO + FLUOROURACIL |
| 290007034 | 290005364 | 1.76 | 80.2 | Palliative (P) | 2014-06-23 | 2014-07-14 | NIVOLUMAB | 02 | N | 290021802 | CAPECITABINE + CISPLATIN |
| 290007035 | 290005365 | 1.7 | 50.4 | Adjuvant (A) | 2016-02-04 | 2016-03-12 | Capecitabine + Oxaliplatin 14day | N | N | 290021803 | CAPECITABINE + OXALIPLATIN |